Equity
€233,550 from €414,237 in 2019
Equity fell by 44% in 6 years.
Pharmacie de la Cloche
Lifetime
20 annual accounts with figures on one time axis, 26 filings since 2000peak €330,791 (2019)
€240,237▲ 14.3%
lowest -€43,992 (2008)
€36,388▲ €41,597
peak €414,237 (2019)
€233,550▲ 10.1%
€352,739▲ 0.4%
peak 2.9 FTE (2014)
2.7 FTEunchanged
Board4 names since 2018
1 directorDELPHARM
Owners
100%DELPHARM
Documentsfilings and deeds
10-07-202621 days before the deadline
2025abbreviated format
Gross margin from €210,099 to €240,237Back to profit: €36,388Cash from €40,771 to €55,955
Key points
from the 2025 annual accountsChecked score
89
Excellent
Financially stronger than 57% of micro companies in retail trade (NACE 47)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.6% across 40,277 companies (NACE 47, micro).
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.3%
01-2025: 0.3%● unchanged vs 12-2024
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025
05-2025: 0.3%● unchanged vs 04-2025
06-2025: 0.3%● unchanged vs 05-2025
07-2025: 0.4%▲ +0.1 percentage points vs 06-2025
08-2025: 0.7%▲ +0.3 percentage points vs 07-2025highest value
09-2025: 0.3%▼ -0.4 percentage points vs 08-2025
10-2025: 0.3%● unchanged vs 09-2025
11-2025: 0.3%● unchanged vs 10-2025
12-2025: 0.3%● unchanged vs 11-2025
01-2026: 0.3%● unchanged vs 12-2025
02-2026: 0.3%● unchanged vs 01-2026
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.4%▲ +0.1 percentage points vs 04-2026
06-2026: 0.3%▼ -0.1 percentage points vs 05-2026
07-2026: 0.4%▲ +0.1 percentage points vs 06-2026
08-2026: 0.2%▼ -0.2 percentage points vs 07-2026lowest value
09-2026: 0.2%● unchanged vs 08-2026lowest value
10-2026: 0.2%● unchanged vs 09-2026lowest value
11-2026: 0.2%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
Sector: Retail trade (NACE 47)
lowers risk
Founded in 2000
Figures for financial year 2025 (filed on 10-07-2026)
Equity €233,550 (39.8% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 55% of them on solvency, 47% on liquidity, 64% on profitability and 61% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 31,368 companies had the same profile as Pharmacie de la Cloche has now. Each dot stands for 79 companies, two years later.
93.5%
were still trading
5.9%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of Pharmacie de la Cloche itself: 0.2% within 12 months.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,368 companies, not a prediction for Pharmacie de la Cloche. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €20,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.75 (1.71 in 2024), above the usual 1.5. Short-term debt is 33.2% and cash 9.5% of total assets. However, 60.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-07-2026, 21 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
21 days early
2024
14 days late
2023
54 days early
2022
68 days early
2021
82 days early
2020
109 days early
2019
93 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 59 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 8 June (4 of the last 5 accounts filed within 32 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0471129889
Registered office moved within Amay
New registered office: rue de la cloche, 1 à 4540 Amay · Previous registered office: rue Albert 1er, 31 à 4540 AMAY · Resignations: Liliana Azzolina (director) and Jean-Pierre Coheur (director) · General meeting of 26-03-2021 · Gazette deed
Demerger: IMMOCOPHAZ splits off to PATRIMMOCO
Company renamed from IMMOCOPHAZ to Pharmacie de la Cloche · Change of role: Jean-Pierre COHEUR, from director to managing director · Resignation: AZZOLINA Liliana (director) · General meeting of 16-07-2020 · Gazette deed
Demerger proposal: IMMOCOPHAZ splits off to PATRIMMOCO
Capital from €125,000 to €165,000 · Capital from €165,000 to €365,000 · Liliane AZZOLINA holds 250 shares · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Pharmacie de la Cloche Amay | €586,289 | €240,237 | 39.8% | 2.7 |
| PHARMACIE DE BOIS DE BREUX Liège | €583,147 | €283,121 | 29.4% | 2.5 |
| Pharmacie Darimont Theux | €530,681 | €214,805 | 72.5% | 2.3 |
| Pharmacie BARBAY Namur | €512,805 | €240,609 | 45.8% | 2.6 |
| APOTHEEK MATTHIJS Huldenberg | €564,034 | €259,073 | 60.4% | 2.9 |
| APOTHEEK CURAVIT Kalmthout | €700,757 | €254,159 | 48.5% | 2.5 |
| LIBO CONSULT Halen | €516,567 | €243,596 | 11.1% | 2.4 |
These companies have the same main activity as Pharmacie de la Cloche: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €513,000 and €701,000, founded between 1997 and 2004.
Official details
Source: KBO- Status
- Active since 23-02-2000Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.167.418.2804540 Amay, since 01-01-2008
- Financial year end
- 31 December
- Peppol
- Reachable since 23-12-2025
Annual accounts 2025
- €586,289▲ 4.0%
- Employeeson 31-12-2025
- 3=
- Filing
- Filed on 10-07-2026, 21 days before the end of the filing period
Insights on Pharmacie de la Cloche
Pharmacie de la Cloche files the abbreviated format. That format states no turnover. The gross margin rose from €11,302 in 2006 to €240,237 in 2025.
The balance sheet grew most from 2007 to 2009 through fixed assets.
DELPHARM holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Pharmacie de la Cloche
- What is the company number of Pharmacie de la Cloche?
- The company number of Pharmacie de la Cloche is 0471.129.889. The VAT number is the same number with BE in front: BE 0471.129.889.
- Where is Pharmacie de la Cloche based?
- The registered office is at Rue de la Cloche 1, 4540 Amay.Company details
- What does Pharmacie de la Cloche do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Pharmacie de la Cloche?
- Pharmacie de la Cloche is a private limited company (BV).
- When was Pharmacie de la Cloche founded?
- Pharmacie de la Cloche was founded on 23-02-2000.
- Is Pharmacie de la Cloche still active?
- Yes, Pharmacie de la Cloche is an active enterprise in the KBO register.
- How many employees does Pharmacie de la Cloche have?
- Pharmacie de la Cloche had an average of 2.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does Pharmacie de la Cloche fall under?
- In its 2025 annual accounts, Pharmacie de la Cloche states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of Pharmacie de la Cloche?
- The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €240,237 and 51 comparable companies (NACE 477). It probably lies between €750,000 and €2.2m.
- Is Pharmacie de la Cloche profitable?
- In financial year 2025, Pharmacie de la Cloche made a profit of €36,388.
- Where can I find the annual accounts of Pharmacie de la Cloche?
- Pharmacie de la Cloche filed 26 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Pharmacie de la Cloche due?
- Pharmacie de la Cloche must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.